In this episode of Inside Biotech, we sit down with John Marlowe and Pete Kane to explore how patient-driven innovation is transforming research on rare diseases and oncology. John shares his own 15-year medical odyssey filled with misdiagnoses and being told his symptoms were “in his head” and how his relentless determination led him to long-read sequencing which finally revealed his rare disease diagnosis. Pete, founder of Research to the People, explains how his nonprofit brings together scientists, engineers, and patients in open hackathons to tackle unsolved medical mysteries. Together, John and Pete reveal what happens when “scientific cowboys and cowgirls” unite—merging cutting-edge genomics, AI, and the power of community and collaboration to push the boundaries of diagnosis and treatment. Their story is a powerful reminder that the future of biotech is not just about technology, but about people coming together to rewrite what’s possible.
In this episode of Inside Biotech, we sit down with John Marlowe and Pete Kane to explore how patient-driven innovation is transforming research on rare diseases and oncology. John shares his own 15-year medical odyssey filled with misdiagnoses and being told his symptoms were “in his head” and how his relentless determination led him to long-read sequencing which finally revealed his rare disease diagnosis. Pete, founder of Research to the People, explains how his nonprofit brings together scientists, engineers, and patients in open hackathons to tackle unsolved medical mysteries.
Together, John and Pete reveal what happens when “scientific cowboys and cowgirls” unite—merging cutting-edge genomics, AI, and the power of community and collaboration to push the boundaries of diagnosis and treatment. Their story is a powerful reminder that the future of biotech is not just about technology but about people coming together to rewrite what’s possible.